• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞增殖在再生性疾病和肿瘤性疾病中的作用。

Role of cell proliferation in regenerative and neoplastic disease.

作者信息

Cohen S M

机构信息

University of Nebraska Medical Center, Omaha 68198-3135, USA.

出版信息

Toxicol Lett. 1995 Dec;82-83:15-21. doi: 10.1016/0378-4274(95)03542-7.

DOI:10.1016/0378-4274(95)03542-7
PMID:8597044
Abstract

DNA replication does not have 100% fidelity. Consequently, a chemical can increase the risk of cancer either by directly damaging DNA (genotoxic) or by increasing the number of cell replications, or both. Increased cell proliferation can be produced by increasing cell births (by direct mitogenesis or regeneration following toxicity), or decreasing cell deaths (by inhibiting apoptosis or differentiation). Cell proliferation can affect the dose-response curve for genotoxic carcinogens and is the basis for carcinogenicity by nongenotoxic agents. Bladder carcinogens will be used to illustrate these mechanisms, and their implications with respect to human risk assessment will be presented.

摘要

DNA复制并非具有100%的保真度。因此,一种化学物质可通过直接损伤DNA(基因毒性)或增加细胞复制数量,或两者兼而有之,来增加患癌风险。细胞增殖增加可通过增加细胞生成(通过直接有丝分裂或毒性后的再生)或减少细胞死亡(通过抑制细胞凋亡或分化)来实现。细胞增殖可影响基因毒性致癌物的剂量反应曲线,并且是非基因毒性剂致癌性的基础。将以膀胱致癌物为例来说明这些机制,并阐述其对人类风险评估的意义。

相似文献

1
Role of cell proliferation in regenerative and neoplastic disease.细胞增殖在再生性疾病和肿瘤性疾病中的作用。
Toxicol Lett. 1995 Dec;82-83:15-21. doi: 10.1016/0378-4274(95)03542-7.
2
Cell proliferation in carcinogenesis.癌症发生过程中的细胞增殖
Science. 1990 Aug 31;249(4972):1007-11. doi: 10.1126/science.2204108.
3
Cell proliferation in the bladder and implications for cancer risk assessment.
Toxicology. 1995 Sep 1;102(1-2):149-59. doi: 10.1016/0300-483x(95)03044-g.
4
Use of cell proliferation data in modeling urinary bladder carcinogenesis.细胞增殖数据在膀胱致癌作用建模中的应用。
Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):111-3. doi: 10.1289/ehp.93101s5111.
5
Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion.
Pharmacol Ther. 1996;71(1-2):225-52. doi: 10.1016/0163-7258(96)00069-1.
6
Reply to Gaylor. Data for high dose and low dose that do not visually fall near a line representing the other data.回复盖勒。高剂量和低剂量的数据在视觉上并不靠近代表其他数据的直线。
Toxicol Pathol. 2003 Nov-Dec;31(6):711. doi: 10.1080/01926230390241909.
7
The male rat carcinogens limonene and sodium saccharin are not mutagenic to male Big Blue rats.
Mutagenesis. 2001 Jul;16(4):329-32. doi: 10.1093/mutage/16.4.329.
8
Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.作为接触致癌物指标的活性细胞死亡(凋亡)和细胞增殖
IARC Sci Publ. 1999(146):273-85.
9
2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation.
Pharmacol Ther. 1996;71(1-2):83-105. doi: 10.1016/0163-7258(96)00063-0.
10
Can the concept of hormesis Be generalized to carcinogenesis?兴奋效应的概念能推广到致癌作用吗?
Regul Toxicol Pharmacol. 1998 Dec;28(3):230-41. doi: 10.1006/rtph.1998.1267.

引用本文的文献

1
Risk Analysis Implications of Dose-Response Thresholds for NLRP3 Inflammasome-Mediated Diseases: Respirable Crystalline Silica and Lung Cancer as an Example.NLRP3炎性小体介导疾病的剂量反应阈值的风险分析意义:以可吸入结晶二氧化硅与肺癌为例
Dose Response. 2019 Apr 2;17(2):1559325819836900. doi: 10.1177/1559325819836900. eCollection 2019 Apr-Jun.
2
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.雷洛昔芬、贝沙罗汀及其联合应用对化学诱导大鼠结肠腺瘤进展为腺癌的化学预防作用。
Cancer Prev Res (Phila). 2013 Dec;6(12):1251-61. doi: 10.1158/1940-6207.CAPR-13-0249. Epub 2013 Sep 30.
3
Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways.
用银杏叶提取物处理两年的B6C3F1小鼠中的肝细胞癌在癌症基因突变和基因组途径方面与自发性肝肿瘤不同。
Toxicol Pathol. 2013 Aug;41(6):826-41. doi: 10.1177/0192623312467520. Epub 2012 Dec 21.
4
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.尽管临床前研究结果不利,但药物研发仍取得成功 第1部分:解决问题的流程及最重要的发现
J Toxicol Pathol. 2010 Dec;23(4):189-211. doi: 10.1293/tox.23.189. Epub 2010 Dec 16.
5
Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat.补偿性再生作为伏马菌素B1在F344/N/Nctr BR大鼠中诱发肾小管癌变的一种机制。
Environ Health Perspect. 2001 May;109 Suppl 2(Suppl 2):309-14. doi: 10.1289/ehp.01109s2309.
6
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.鞘脂代谢紊乱作为伏马菌素致癌作用的机制。
Environ Health Perspect. 2001 May;109 Suppl 2(Suppl 2):301-8. doi: 10.1289/ehp.01109s2301.